Home > Insider Trading > Filing (0001264124-11-000070)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
881464	Amylin Pharmaceuticals Inc	AMLN	Pharmaceutical Preparations (2834)	330266089

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1236394	G Orville Kolterman	9360 Towne Centre Dr San Diego CA 92121	Svp, Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2011-10-03	12,500	$5.73	168,093	No	4	M	Direct
Common Stock	Disposition	2011-10-03	12,500	$8.75	155,593	No	4	S	Direct
Common Stock	Acquisiton	2011-10-03	2,500	$5.73	158,093	No	4	M	Direct
Common Stock	Disposition	2011-10-03	2,500	$8.75	155,593	No	4	S	Direct
Common Stock	Acquisiton	2011-10-04	96	$5.73	155,689	No	4	M	Direct
Common Stock	Disposition	2011-10-04	62	$8.75	155,627	No	4	F	Direct
Common Stock	Acquisiton	2011-10-04	2,404	$5.73	158,031	No	4	M	Direct
Common Stock	Disposition	2011-10-04	1,574	$8.75	156,457	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Incentive Stock Option (right to buy)	Disposition	2011-10-03	12,500	$0.00	12,500	$5.73
Common Stock	Incentive Stock Option (right to buy)	Disposition	2011-10-04	96	$0.00	96	$5.73
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2011-10-03	2,500	$0.00	2,500	$5.73
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2011-10-04	2,404	$0.00	2,404	$5.73

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
96	2011-10-04	No	4	M	Direct
0	2011-10-04	No	4	M	Direct
2,404	2011-10-04	No	4	M	Direct
0	2011-10-04	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	12,294	Indirect	Indirect-401k
Common Stock	6,445	Indirect	by ESOP

Footnotes

Includes 457 shares recently acquired under the Company's Employee Stock Purchase Plan.
The sale was affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Represents shares delivered to the Company to pay the exercise price of the option.
These shares fully vested four years from the date of the reporting person's participation in the ESOP in four equal annual installments and are generally distributed upon termination of employment.
25% of shares vested one year from date of grant and the remainder vested monthly over the next three years becoming fully vested four years from date of grant.